PSA above 0 2 after RP in 2020 but psma pet scan is negative

Posted by knoyes01 @knoyes01, Oct 14 9:59pm

RP in 2020. All went well then a couple years later PSA starts rising (about 2.7 years ago) and went above 0.2. Had psma scan last week. All negative. Dr suggests radiation at pelvic area even though they dont know where cancer is for sure. Will do a MRI and discuss with oncology et al before deciding to start radiation

Just weird that dont know where cancer exists so educated guess is pelvic area.

Any information will be appreciated

I am at a good hospital and cancer center

Interested in more discussions like this? Go to the Prostate Cancer Support Group.

Profile picture for knoyes01 @knoyes01

Waiting until psa is 1.0 makes sense in that i now know where the cancer is located with higher confidence and not applying radiation to healthy areas. However, then there is the risk the cancer has spread widely. Dr prefers not to take that chance as the treatment is even harsher

Kind of sucks, but it is what it is and I need to decide

Jump to this post

@knoyes01 My second opinion GU at a CCC facility said to wait until 2.0 and they could find it and treat it. Same concerns as you. I can understand getting radiation and ADT at .2 one time in the bed area as it isn't unusual for cells to leak into the area and seems a reasonable hunch. What happens if we have a .2 recurrence after that? And another negative PET Scan? Do we end up on ADT for life or do we wait until 1.0 or 2.0 and then get another PSMA scan hopefully with evidence of where the cancer is? If I have to end up on ADT for life I would like it to be evidenced based. These decisions are emotionally tough. Best wishes on your journey and if you are up to it I would be interested in what you decided and the outcome. Chip

REPLY
Profile picture for chippydoo @chippydoo

@knoyes01 My second opinion GU at a CCC facility said to wait until 2.0 and they could find it and treat it. Same concerns as you. I can understand getting radiation and ADT at .2 one time in the bed area as it isn't unusual for cells to leak into the area and seems a reasonable hunch. What happens if we have a .2 recurrence after that? And another negative PET Scan? Do we end up on ADT for life or do we wait until 1.0 or 2.0 and then get another PSMA scan hopefully with evidence of where the cancer is? If I have to end up on ADT for life I would like it to be evidenced based. These decisions are emotionally tough. Best wishes on your journey and if you are up to it I would be interested in what you decided and the outcome. Chip

Jump to this post

@chippydoo That’s a great point, Chip…what if after Strike 2, there’s another on the horizon?
I think at that point - even though I am prevention oriented and like to catch things early - I too would wait to see something more visible.
I would think (hope!) that the lesion(s) would not be in the bed/nodes but probably a rib or an area that can be zapped with SBRT. After that, you are in a prime position to see a drop - or not - in Your PSA and can either be done at that point or opt for a period of ADT.
These are really hard decisions and you have to do your homework; but many times it all comes down to your own personality and mind set…
Phil

REPLY
Profile picture for kujhawk1978 @kujhawk1978

What can I say...

You could, as @jeffmarc says, initiate the tried but not necessarily true standard of care and do SRT...and "hope" that works... As a friend of mine said long, long ago, "hope is not a method!"

There are choices, in part, may be a function of your clinical data.

Pathology Report
Decipher Test
PSA test results
Genomic Testing

PSA tests results can be used to calculate PSADT and PSAV,
The pathology report gives you clinical data such as GS, GG, SV, ECE, Margins...
It is useful to understand the risk category in making treatment decisions in concert with your medical team.

You can be aggressive in your approach, including WPLN radiation to and short-term systemic therapy. What is short term, may be six months, up to 12-18 though 24 months is in play.

You can forgo the SRT only and let your PSA increase to between .5-1.0, doubling your statistical probability of locating the recurrence and informing the treatment decision.

I am high risk. When I had BCR after surgery (see attached clinical history), I discussed adding WPLN and short term systemic therapy to the SRT. There was data emerging from clinical trials that indicated in high risk cases, the PCa had already moved into the PLNs. My medical team dismissed the idea, no "long term" data supporting it. I acquiesced, you guessed it, SRT was an epic failure.

Would my way have changed the course of my PCa, would I have been cured, we'll never know! The takeaway for me was be aggressive, I have high risk PCa. The next treatment decision, triplet therapy was in part, founded on my mistake with SRT.

That's my experience though. I don't see enough clinical data in your post to inform your decision.

I'm with @brianjarvis though.

Kevin

Jump to this post

@kujhawk1978 What is PLN and WPLN?

REPLY

PLN - Pelvic Lymph Node
WPLN - Whole Pelvic Lymph Node

REPLY
Profile picture for kujhawk1978 @kujhawk1978

What can I say...

You could, as @jeffmarc says, initiate the tried but not necessarily true standard of care and do SRT...and "hope" that works... As a friend of mine said long, long ago, "hope is not a method!"

There are choices, in part, may be a function of your clinical data.

Pathology Report
Decipher Test
PSA test results
Genomic Testing

PSA tests results can be used to calculate PSADT and PSAV,
The pathology report gives you clinical data such as GS, GG, SV, ECE, Margins...
It is useful to understand the risk category in making treatment decisions in concert with your medical team.

You can be aggressive in your approach, including WPLN radiation to and short-term systemic therapy. What is short term, may be six months, up to 12-18 though 24 months is in play.

You can forgo the SRT only and let your PSA increase to between .5-1.0, doubling your statistical probability of locating the recurrence and informing the treatment decision.

I am high risk. When I had BCR after surgery (see attached clinical history), I discussed adding WPLN and short term systemic therapy to the SRT. There was data emerging from clinical trials that indicated in high risk cases, the PCa had already moved into the PLNs. My medical team dismissed the idea, no "long term" data supporting it. I acquiesced, you guessed it, SRT was an epic failure.

Would my way have changed the course of my PCa, would I have been cured, we'll never know! The takeaway for me was be aggressive, I have high risk PCa. The next treatment decision, triplet therapy was in part, founded on my mistake with SRT.

That's my experience though. I don't see enough clinical data in your post to inform your decision.

I'm with @brianjarvis though.

Kevin

Jump to this post

@kujhawk1978 I've really appreciated the information you've shared for me to use to encourage my husband to ask for an ADT vacation after almost 5yrs status quo. But, I have been assertive w/doctors over the years & have a few do what I requested & it be the wrong thing. So I'm a little gun-shy when it comes to my husband's health, ha! And some of the doctors are so intimidating! My head is about to explode from all the info I've tried to gather from this group. I do need to take a little more time from my studying for praying. I can tell the difference when I do. Thanks again!

REPLY
Profile picture for Jonesfit65 @jonesfit65

@kujhawk1978 I've really appreciated the information you've shared for me to use to encourage my husband to ask for an ADT vacation after almost 5yrs status quo. But, I have been assertive w/doctors over the years & have a few do what I requested & it be the wrong thing. So I'm a little gun-shy when it comes to my husband's health, ha! And some of the doctors are so intimidating! My head is about to explode from all the info I've tried to gather from this group. I do need to take a little more time from my studying for praying. I can tell the difference when I do. Thanks again!

Jump to this post

@jonesfit65

You are not alone in what you are experiencing....https://www.urotoday.com/index.php?option=com_content&view=article&id=163910:experience-of-uncertainty-in-prostate-cancer-a-qualitative-study&catid=1134&utm_source=newsletter_14741&utm_medium=email&utm_campaign=prostate-cancer-daily

With the plethora of choices brought by advances in imaging and treatment through medical research comes the possibility of "paralysis by analysis."

The NCN and AUA guidelines offer a starting point for discussions with our medical team. They are the science based, the clinical trials, peer reviewed...

However, it is that rigorous scientific process which also may hinder decision making. They may be "outdated" given the pace of change. They are population based so your husband's clinical data not fit exactly to the guidelines.

There are other valid web based resources, PCRI, PCF, the NCCN Centers of Excellence whose web sites are full with treatment related information.

My experience is there is no single "right" decision. There are "good " decisions.

Once I make mine in concert with my medical team I don't look back and ask "was that the "right one!?"

I look to the present, is it working?

Depending on one's age, other health factors and consequent life expectancy it may help to adjust the window of expectations for treatment outcomes. I ask myself, will this work for the next 3-5 years? I am not concerned about the 10-15 year outcome. Why, well, overall survival is hard to measure because of time. Also, in that 10-15 year window, too much changes to compare the original treatment with new ones brought about by medical research.

My triplet therapy decision went against the guidelines but brought darn near five years off treatment. Same with my doublet therapy, at 20 months now, next labs in January.

Don't be hesitant to fire someone from one's medical team if they are not supportive of shared decision making, are not active listeners, closed to new ideas that challenge existing paradigms...,albeit with solid scientific research supporting the new ideas.

Kevin

REPLY

Yes indeed...that is the frustrating and quixotic feature to a PSA level that can slowly rise above the cut-off value of greater than 0.1 ng/ml. Clinical laboratory testing for PSA can detect PSA levels down that low, but a PET scan with Gallium-68 can't detect or identify "where" the prostate cancer cells are growing...there aren't enough of them for the Gallium-68 uptake for detection and measurement by the PET scan. I have not "arrived" there yet, and I hope that I never do, but this is all due to highly sensitive and specific testing for PSA down to the nanogram level, but unfortunately unmatched in radiological technology's sensitivity and specificity for prostate cancer. Before prostatectomy - and if we have cancer - our prostate gland lights up like a jack-o'-lantern during a PET Scan, but after the prostatectomy, it would take a LONG time for enough cancerous prostatic cells to be detectable, even though they are making PSA that "is" detectable by clinical lab testing. And...
In my situation, I am getting ready to discuss radiation therapy with a RO because as a pT3b I am at high risk for recurrence, so my urologist wants at least the consultation with the RO, even though at six months post-op, my first two PSA values have been < 0.1 ng/ml (see my other post asking all of you pT3b's if you had radiation, and how long after surgery, etc.

REPLY
Please sign in or register to post a reply.